MMedication Read More PBS dispute could see MS patients pay thousands for crucial drugs Ocrevus and KesimptaJuly 7, 2026 A dispute over how Australia prices medicines has sparked fears 10,000 people with multiple sclerosis will be forced…
MMedication Read More Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints NewsFebruary 12, 2026 Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints News Roche unveils data behind BTK inhibitor’s phase…